| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -33.42 | -30.30 | 38.86 | 116.87 |
| Net Changein Cash | -6.72 | -0.41 | -11.59 | 3.48 |
| Cash Taxes Paid | 11.47 | 11.67 | 8.11 | 17.11 |
| Net Income/ Starting Line | 39.57 | 31.95 | 40.15 | 53.50 |
| Total Cash Dividends Paid | -5.17 | -6.81 | -8.51 | -8.51 |
| Changesin Working Capital | -1.53 | -8.04 | -28.95 | -55.79 |
| Cashfrom Operating Activities | 64.51 | 48.13 | 23.60 | 8.81 |
| Cash Interest Paid | 13.13 | 14.94 | 12.59 | 2.54 |
| Cashfrom Financing Activities | -51.72 | -26.04 | 41.76 | 111.61 |
| Depreciation/ Depletion | 16.80 | 17.17 | 20.70 | 16.58 |
| Other Investing Cash Flow Items Total | 1.59 | 1.74 | 0.76 | -20.88 |
| Capital Expenditures | -20.59 | -24.40 | -77.76 | -95.71 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | -0.51 | 0.16 | 0.05 | -0.35 |
| Non- Cash Items | 9.66 | 7.05 | -8.31 | -5.48 |
| Financing Cash Flow Items | -13.13 | 11.06 | 11.41 | 3.65 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -19.00 | -22.65 | -77.00 | -116.59 |
| Issuance( Retirement)of Stock Net | - | - | 0.00 | -0.40 |
Hester Biosciences Dividend Hester Biosciences Bonus Hester Biosciences News Hester Biosciences AGM Hester Biosciences Rights Hester Biosciences Splits Hester Biosciences Board Meetings Hester Biosciences Key Metrics Hester Biosciences Shareholdings Hester Biosciences Profit Loss Hester Biosciences Balance Sheet Hester Biosciences Q1 Results Hester Biosciences Q2 Results Hester Biosciences Q3 Results Hester Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks